Verona Pharma’s ensifentrine inches closer to approval decision in COPD
The agency has set a PDUFA target action date to June 2024, with no current plans for an advisory meeting in the works.
The agency has set a PDUFA target action date to June 2024, with no current plans for an advisory meeting in the works.
What's Your Reaction?
